Synergetics USA, Inc. (SURG)
-NasdaqCM 3.06 
0.09(2.86%) 4:00PM EDT
| Prev Close: | 3.15 |
|---|
| Open: | 3.13 |
|---|
| Bid: | 3.06 x 100 |
|---|
| Ask: | 3.08 x 100 |
|---|
| 1y Target Est: | 5.00 |
|---|
| Beta: | 1.12 |
|---|
| Next Earnings Date: | 10-Jun-13 |
|---|
| Day's Range: | 3.05 - 3.17 |
|---|
| 52wk Range: | 2.88 - 5.75 |
|---|
| Volume: | 22,266 |
|---|
| Avg Vol (3m): | 134,166 |
|---|
| Market Cap: | 75.67M |
|---|
| P/E (ttm): | 26.38 |
|---|
| EPS (ttm): | 0.12 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- SYNERGETICS USA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Thu, Mar 28)
- Synergetics USA Inc. Stock Downgraded (SURG)at TheStreet(Wed, Mar 20)
- Game Changers in the Medical Device Space: An Expert Analyst Discusses Performance Drivers for Wright Medical Group (WMGI) and Baxter International (BAX)Wall Street Transcript(Tue, Mar 19)
- Synergetics: Unlocking Value, A Tough Textbook Caseat Seeking Alpha(Mon, Mar 18)
- SYNERGETICS USA INC FinancialsEDGAR Online Financials(Sat, Mar 16)
- New Star Analyst Rankings for Synergetics USA, Inc.StarMine(Wed, Mar 13)
- Synergetics USA's CEO Discusses F2Q13 Results - Earnings Call Transcriptat Seeking Alpha(Wed, Mar 13)
- W.W. Grainger Pushed to Hold and 3 More Analyst Downgrades to Knowat Wall St. Cheat Sheet(Wed, Mar 13)
- Peregrine Pharmaceuticals, Synergetics Announce Earningsat Forbes(Wed, Mar 13)
- Synergetics posts $1.4 million Q2 lossat bizjournals.com(Wed, Mar 13)
- Synergetics downgraded by WunderlichBriefing.com(Wed, Mar 13)
- Synergetics Earnings: Here’s Why the Stock is Rising Nowat Wall St. Cheat Sheet(Tue, Mar 12)
- SYNERGETICS USA INC Files SEC form 8-K, Financial Statements and ExhibitsEDGAR Online(Tue, Mar 12)
- SYNERGETICS USA INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, Mar 12)
- Synergetics Reports Second Quarter Fiscal Year 2013 ResultsMarketwired(Tue, Mar 12)
Key Statistics
| Forward P/E (1 yr): | 13.30 |
|---|
| P/S (ttm): | 1.30 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jul-13)
: | 0.08 |
|---|
| Quarterly EPS Est
(Apr-13)
: | 0.03 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | 2.68 |
|---|
Business Summary
Synergetics USA, Inc., a medical device company, provides precision surgical devices for the ophthalmology and neurosurgery markets in the United States and internationally.
View More